Literature DB >> 12368227

Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells.

Alberto Papi1, Nikolaos G Papadopoulos, Luminita A Stanciu, Cinzia M Bellettato, Silvano Pinamonti, Klaus Degitz, Stephen T Holgate, Sebastian L Johnston.   

Abstract

Rhinoviruses are the major cause of common colds and of asthma exacerbations. Intercellular adhesion molecule-1 (ICAM-1) has a central role in airway inflammation and is the receptor for 90% of rhinoviruses. Rhinovirus infection of airway epithelium induces ICAM-1. Because redox state is directly implicated in inflammatory responses via molecular signaling mechanisms, here we studied the effects of reducing agents on rhinovirus-induced ICAM-1 expression, mRNA up-regulation, promoter activation, and nuclear factor activation. To investigate the effects of rhinovirus infection on the intracellular redox balance, we also studied whether rhinovirus infection triggers the production of reactive oxygen species. We found that reduced (GSH) but not oxidized (GSSG) glutathione (1-100 microM) inhibited in a dose-dependent manner rhinovirus-induced ICAM-1 up-regulation and mRNA induction in primary bronchial and A549 respiratory epithelial cells. GSH but not GSSG also inhibited rhinovirus-induced ICAM-1 promoter activation and rhinovirus-induced NF-kB activation. In parallel, we found that rhinovirus infection induced a rapid increase of intracellular superoxide anion that was maximal at the time of NF-kB activation. This oxidant generation was completely inhibited by GSH. We conclude that redox-mediated intracellular pathways represent an important target for the therapeutic control of rhinovirus-induced diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368227     DOI: 10.1096/fj.02-0118fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

Review 1.  Oxidants and asthma.

Authors:  G Caramori; A Papi
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

2.  Rhinovirus replication in human macrophages induces NF-kappaB-dependent tumor necrosis factor alpha production.

Authors:  Vasile Laza-Stanca; Luminita A Stanciu; Simon D Message; Michael R Edwards; James E Gern; Sebastian L Johnston
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Role of xanthine oxidase activation and reduced glutathione depletion in rhinovirus induction of inflammation in respiratory epithelial cells.

Authors:  Alberto Papi; Marco Contoli; Pierluigi Gasparini; Laura Bristot; Michael R Edwards; Milvia Chicca; Marilena Leis; Adalberto Ciaccia; Gaetano Caramori; Sebastian L Johnston; Silvano Pinamonti
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

4.  Human rhinovirus 1B exposure induces phosphatidylinositol 3-kinase-dependent airway inflammation in mice.

Authors:  Dawn C Newcomb; Umadevi S Sajjan; Deepti R Nagarkar; Qiong Wang; Suparna Nanua; Ying Zhou; Christina L McHenry; Kenneth T Hennrick; Wan C Tsai; J Kelley Bentley; Nicholas W Lukacs; Sebastian L Johnston; Marc B Hershenson
Journal:  Am J Respir Crit Care Med       Date:  2008-02-14       Impact factor: 21.405

Review 5.  Rhinoviruses, allergic inflammation, and asthma.

Authors:  Monica L Gavala; Paul J Bertics; James E Gern
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

Review 6.  Macrolide therapy in respiratory viral infections.

Authors:  Jin-Young Min; Yong Ju Jang
Journal:  Mediators Inflamm       Date:  2012-06-06       Impact factor: 4.711

7.  Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.

Authors:  Narayana Komaravelli; Antonella Casola
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2014-09-30

8.  Effects of (L)-cystine and (L)-theanine supplementation on the common cold: a randomized, double-blind, and placebo-controlled trial.

Authors:  Shigekazu Kurihara; Takenori Hiraoka; Masahisa Akutsu; Eiji Sukegawa; Makoto Bannai; Susumu Shibahara
Journal:  J Amino Acids       Date:  2010-05-12

Review 9.  Pathophysiology of viral-induced exacerbations of COPD.

Authors:  Alfredo Potena; Gaetano Caramori; Paolo Casolari; Marco Contoli; Sebastian L Johnston; Alberto Papi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression.

Authors:  Sonia Carta; Michela Silvestri; Giovanni A Rossi
Journal:  Ital J Pediatr       Date:  2013-05-10       Impact factor: 2.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.